Dongrong Yi

机构：Chinese Academy of Medical Sciences & Peking Union Medical College · ORCID：0009-0009-9903-2734

发表论文 43 篇 · 总被引 855 次 · h-index 17

代表论文

• Repurposing of berbamine hydrochloride to inhibit Ebola virus by targeting viral glycoprotein (2022 · Acta Pharmaceutica Sinica B · 被引 30)
• Development of an mRNA-based therapeutic vaccine mHTV-03E2 for high-risk HPV-related malignancies (2024 · Molecular Therapy · 被引 29)
• SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis (2022 · Signal Transduction and Targeted Therapy · 被引 26)
• Repurposing of HIV/HCV protease inhibitors against SARS-CoV-2 3CLpro (2022 · Antiviral Research · 被引 23)
• Immunogenicity and effectiveness of an mRNA therapeutic vaccine for HPV-related malignancies (2024 · Life Science Alliance · 被引 18)
• MOV10 recruits DCP2 to decap human LINE‐1 RNA by forming large cytoplasmic granules with phase separation properties (2023 · EMBO Reports · 被引 17)